5003Inhibition of PCSK9 reduces infarct size and arrhythmia susceptibility in cardiac ischeamia/reperfusion injury through attenuating mitochondrial dysfunction and increasing connexin43 phosphorylation. (28th August 2018) - Palee, S; McSweeney, C; Maneechote, C; Moisescu, D M; Jaiwongkam, T; Kerdphoo, S; Chattipakorn, S C; Chattipakorn, N